INLB

Item 9 Labs Corp. INLB

INLB
Item 9 Labs Corp. IDCN
Indocan Resources Inc. CNNC
Cannonau Corp. GEATF
Radiko Holdings Corp. MJARF
MJardin Group, Inc. CBGL
Cannabis Global, Inc. HENC
Hero Technologies Inc. ISOLF
Isodiol International Inc. IMMB
Immunotech Laboratories, Inc. SCPX
Scorpius Holdings, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode INLB IDCN CNNC GEATF MJARF CBGL HENC ISOLF IMMB SCPX
6M 0.00 % 0.00 % 50.00 % 0.00 % 900.00 % 0.00 % 0.00 % 900.00 % 0.00 % -99.17 %
YTD 0.00 % 0.00 % 0.00 % 0.00 % 900.00 % -33.33 % 0.00 % 9 900.00 % 0.00 % -99.98 %
1Y 0.00 % 0.00 % -92.68 % 0.00 % 0.00 % 0.00 % 0.00 % 900.00 % -0.99 % -99.99 %
3Y -99.96 % 0.00 % -98.46 % -90.00 % -96.00 % -92.86 % -99.82 % -80.00 % -50.00 % -100.00 %
5Y -99.99 % -93.33 % -99.75 % -99.89 % -99.75 % -99.83 % -99.69 % -99.96 % 0.00 % -100.00 %
10Y -99.92 % -90.00 % 59 900.00 % -99.99 % -100.00 % -99.92 % -99.95 % -100.00 % 0.00 % -100.00 %
From the beginning -100.00 % -99.90 % 93.55 % -99.99 % -100.00 % -93.33 % -99.99 % -100.00 % 0.00 % -100.00 %

Dividend